(Q44969278)

7 December 2017

Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients (English)

1 reference

7 December 2017

1 reference

1

Ljungman P

1 reference

7 December 2017

Dahl H

2

1 reference

7 December 2017

Xu YH

3

1 reference

7 December 2017

Larsson K

4

1 reference

7 December 2017

Brytting M

5

1 reference

7 December 2017

Linde A

6

1 reference

7 December 2017

language of work or name

English

0 references

publication date

5 March 2007

1 reference

Bone Marrow Transplantation

7 December 2017

1 reference

7 December 2017

39

1 reference

7 December 2017

8

1 reference

7 December 2017

497-499

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705617

7 December 2017

0 references

cites work

Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705617

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705617

1 reference

Dimensions Publication ID

7 December 2017

0 references

1 reference